Onc.ai- novel digital clinical management solution- raises $25 Million in Funding
A privately held digital health business named Onc.AI based out of San Carlos, CA, and Canada- working to significantly enhance oncology decision-making; raises a $25 Million funding.
They are developing a pipeline of physician-centered products to realize the potential of precision oncology by utilizing a fast expanding real-world dataset that supports multimodal AI forecasts.
This round of funding was co-led by MassMutual and Action Potential Venture Capital (a GSK venture fund), with participation from Life Extension Ventures and all existing investors, including Blue Venture Fund, Accomplice, Digitalis Ventures, and KdT Ventures.
“In just two years, Onc.AI has assembled a market-leading real-world data asset focused on immuno-oncology, which has enabled the development of a powerful suite of AI models to assist medical oncologists in clinical decision-making. On behalf of the company and existing investors, I would like to welcome MassMutual Alternative Investments and Action Potential Venture Capital as we work together to improve oncology clinical management in a significant way. This major financing will be allocated to achieving the necessary development and regulatory milestones preceding the commercialization of our first product in lung cancer. Proceeds will also be used to support our currently active and future research collaborations with global pharmaceutical leaders.”
said Akshay Nanduri, Co-founder and CEO of Onc.AI.
“Having first learned about Onc.AI through a leading precision-oncology expert, we are thrilled to partner with an exceptional team and help the company as they aim to serve medical oncologists and cancer patients broadly,”
said David Diaz-Casariego, Portfolio Manager of Alternative Investments at MassMutual.
Congratulations Team on the successful round of Funding!
-From Team SpotSaaS
